Saudi Press

Saudi Arabia and the world
Saturday, Nov 29, 2025

Can you trust a negative lateral flow Covid test?

Can you trust a negative lateral flow Covid test?

Analysis: with cold symptoms, it is better to wait for a PCR result rather than risk spreading the virus

You wake up with a pounding head, sore throat and runny nose: you reach for one of those lateral flow tests (LFT) you’ve got stashed away, just to check it is not Covid. If it returns a single red line (negative), then most people will pop a couple of paracetamol and go about business as normal – particularly if you’ve been double-jabbed. It probably is just a cold, after all.

Yet, the emergence of Omicron has thrown a spanner in the works. According to the latest data, just one month after your second Pfizer or AstraZeneca jab, the ability of antibodies to neutralise Omicron is 30 times lower than if you were infected with the Delta variant – reinforcing the message that double-vaccination is no guarantee against infection.

The study follows recent UK Health Security Agency (UKHSA) data, suggesting those who have been double-jabbed with the AstraZeneca vaccine have about 10% protection against symptomatic infection with Omicron six months after their second jab, compared with 40% protection against the Delta variant.

So, if you’re relying on an LFT to guide whether or not it is safe for you to leave the house, the chances of you being infected, despite being vaccinated, just got higher.

The UK government has always stressed that people with Covid symptoms should seek a PCR test, rather than relying on a LFT. Yet, it still defines these symptoms as a high temperature, new, continuous cough and/or a loss or change to your sense of smell or taste – despite widespread evidence that headaches, fatigue, a sore throat or runny nose are also common Covid symptoms.

Also, whereas getting a PCR test involves all the trouble of going online, booking a test, either going to a test centre or waiting to have a test delivered, and then waiting a day or two to receive the test results, a LFT delivers a result within minutes.

OK, we know they’re not as accurate as PCR tests, but they’re pretty accurate – especially if you’ve been vaccinated and/or had Covid recently – right?

It is true that lateral flow tests return an accurate result more often than not: a Cochrane review of 64 studies found that they correctly identify 72% of infected people who have symptoms, and 78% within the first week of becoming ill. Further, the Department of Health and Social Care (DHSC) claims that the Innova LFT detects more than 95% of individuals with highest viral loads – those who are most likely to spread the virus.


Yet, the Medicines and Healthcare products Regulatory Agency (MHRA), has long-expressed concerns that people may be falsely reassured if they test negative on an LFT: it authorised their use as a “red light” – to find infectious people and order them to self-isolate – rather than providing a “green light” to those who test negative.

There are several reasons why your negative LFT might be wrong: you might not be swabbing thoroughly enough, or you could have a dodgy test kit. Of course, these issues can also undermine the accuracy of PCR tests – remember the Wolverhampton testing lab fiasco, that saw up to 43,000 people falsely reassured that they didn’t have Covid, despite many of them testing positive on a LFT? Yet, PCR tests are more sensitive than LFT, meaning they’re more likely to register some virus, even if your swabbing technique isn’t much cop. They’re also much more likely to return a positive result during the early stages of infection, when there’s less virus available to detect.

Studies have suggested that PCR tests start to pick up Sars-CoV-2 roughly 1-3 days before the onset of symptoms (assuming the person is symptomatic) – similar to when people start to become infectious. However, virus levels don’t peak until between the first and fifth day of symptoms, on average. So, if you’re swabbing as soon as you start to feel unwell, that might be too soon to return a positive LFT.

These tests have thankfully freed us from the confines for that first lockdown, when the advice was to self-isolate based on symptoms alone. But with infection levels sky high, Covid symptoms that too often resemble the common cold, and waning immunity from vaccines, perhaps it’s time to reinstate a degree of caution and stay home if we feel unwell – at least until we’ve done a PCR test, or had several days of negative LFTs. Who wants someone else’s cold, anyway?

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Will Saudi Arabia End Up Bankrolling Israel’s Post-Ceasefire Order in Lebanon?
Saudi Arabia’s SAMAI Initiative Surpasses One-Million-Citizen Milestone in National AI Upskilling Drive
Saudi Arabia’s Specialty Coffee Market Set to Surge as Demand Soars and New Exhibition Drops in December
Saudi Arabia Moves to Open Two New Alcohol Stores for Foreigners Under Vision 2030 Reform
Saudi Arabia’s AI Ambitions Gain Momentum — but Water, Talent and Infrastructure Pose Major Hurdles
Tensions Surface in Trump-MBS Talks as Saudi Pushes Back on Israel Normalisation
Saudi Arabia Signals Major Maritime Crack-Down on Houthi Routes in Red Sea
Italy and Saudi Arabia Seal Over 20 Strategic Deals at Business Forum in Riyadh
COP30 Ends Without Fossil Fuel Phase-Out as US, Saudi Arabia and Russia Align in Obstruction Role
Saudi-Portuguese Economic Horizons Expand Through Strategic Business Council
DHL Commits $150 Million for Landmark Logistics Hub in Saudi Arabia
Saudi Aramco Weighs Disposals Amid $10 Billion-Plus Asset Sales Discussion
Trump Hosts Saudi Crown Prince for Major Defence and Investment Agreements
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
Riyadh Metro Records Over One Hundred Million Journeys as Saudi Capital Accelerates Transit Era
Trump’s Grand Saudi Welcome Highlights U.S.–Riyadh Pivot as Israel Watches Warily
U.S. Set to Sell F-35 Jets to Saudi Arabia in Major Strategic Shift
Saudi Arabia Doubles Down on U.S. Partnership in Strategic Move
Saudi Arabia Charts Tech and Nuclear Leap Under Crown Prince’s U.S. Visit
Trump Elevates Saudi Arabia to Major Non-NATO Ally Amid Defense Deal
Trump Elevates Saudi Arabia to Major Non-NATO Ally as MBS Visit Yields Deepened Ties
Iran Appeals to Saudi Arabia to Mediate Restart of U.S. Nuclear Talks
Musk, Barra and Ford Join Trump in Lavish White House Dinner for Saudi Crown Prince
Lawmaker Seeks Declassification of ‘Shocking’ 2019 Call Between Trump and Saudi Crown Prince
US and Saudi Arabia Forge Strategic Defence Pact Featuring F-35 Sale and $1 Trillion Investment Pledge
Saudi Sovereign Wealth Fund Emerges as Key Contender in Warner Bros. Discovery Sale
Trump Secures Sweeping U.S.–Saudi Agreements on Jets, Technology and Massive Investment
Detroit CEOs Join White House Dinner as U.S.–Saudi Auto Deal Accelerates
Netanyahu Secures U.S. Assurance That Israel’s Qualitative Military Edge Will Remain Despite Saudi F-35 Deal
Ronaldo Joins Trump and Saudi Crown Prince’s Gala Amid U.S.–Gulf Tech and Investment Surge
U.S.–Saudi Investment Forum Sees U.S. Corporate Titans and Saudi Royalty Forge Billion-Dollar Ties
Elon Musk’s xAI to Deploy 500-Megawatt Saudi Data Centre with State-backed Partner HUMAIN
U.S. Clears Export of Advanced AI Chips to Saudi Arabia and UAE Amid Strategic Tech Partnership
xAI Selects Saudi Data-Centre as First Customer of Nvidia-Backed Humain Project
A Decade of Innovation Stagnation at Apple: The Cook Era Critique
President Trump Hosts Saudi Crown Prince Mohammed bin Salman in Washington Amid Strategic Deal Talks
Saudi Crown Prince to Press Trump for Direct U.S. Role in Ending Sudan War
Trump Hosts Saudi Crown Prince: Five Key Takeaways from the White House Meeting
Trump Firmly Defends Saudi Crown Prince Over Khashoggi Murder Amid Washington Visit
Trump Backs Saudi Crown Prince Over Khashoggi Killing Amid White House Visit
Trump Publicly Defends Saudi Crown Prince Over Khashoggi Killing During Washington Visit
President Donald Trump Hosts Saudi Crown Prince Mohammed bin Salman at White House to Seal Major Defence and Investment Deals
Saudi Arabia’s Solar Surge Signals Unlikely Shift in Global Oil Powerhouse
Saudi Crown Prince Receives Letter from Iranian President Ahead of U.S. Visit
Saudi Arabia’s Crown Prince Begins Washington Visit to Cement Long-Term U.S. Alliance
Saudi Crown Prince Meets Trump in Washington to Deepen Defence, AI and Nuclear Ties
Saudi Arabia Accelerates Global Mining Strategy to Build a New Economic Pillar
Crown Prince Mohammed bin Salman Arrives in Washington to Reset U.S.–Saudi Strategic Alliance
Saudi-Israeli Normalisation Deal Looms, But Riyadh Insists on Proceeding After Israeli Elections
Saudis Prioritise US Defence Pact and AI Deals, While Israel Normalisation Takes Back Seat
×